- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
- 18 Mar 24 425 Business combination disclosure
- 15 Mar 24 F-4/A Registration of securities (foreign) (amended)
- 26 Jan 24 425 Business combination disclosure
- 19 Jan 24 F-4/A Registration of securities (foreign) (amended)
- 12 Dec 23 425 Business combination disclosure
- 28 Nov 23 F-4/A Registration of securities (foreign) (amended)
- 22 Nov 23 425 Business combination disclosure
-
21 Aug 23 F-4 Registration of securities (foreign)
Exhibit 23.2
INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM’S CONSENT
We consent to the inclusion in this Registration Statement of Baird Medical Investment Holdings Limited on Form F-4 of our report dated March 29, 2023, which includes an explanatory paragraph as to the company’s ability to continue as a going concern, with respect to our audits of the financial statements of ExcelFin Acquisition Corp. as of December 31, 2022 and 2021 and for the year ended December 31, 2022 and the period from March 15, 2021 (inception) through December 31, 2021, which report appears in the Prospectus, which is part of this Registration Statement. We also consent to the reference to our Firm under the heading “Experts” in such Prospectus.
/s/ Marcum LLP
Hartford, CT
August 21, 2023
1